These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25045689)

  • 1. Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes.
    Bettini R; Bonferoni MC; Colombo P; Zanelotti L; Caramella C
    Biomed Res Int; 2014; 2014():671532. PubMed ID: 25045689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of complex solubility on formulations based on lambda carrageenan and basic drugs.
    Aguzzi C; Bonferoni MC; Fortich MR; Rossi S; Ferrari F; Caramella C
    AAPS PharmSciTech; 2002; 3(3):E27. PubMed ID: 12916942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems.
    Tapia C; Escobar Z; Costa E; Sapag-Hagar J; Valenzuela F; Basualto C; Gai MN; Yazdani-Pedram M
    Eur J Pharm Biopharm; 2004 Jan; 57(1):65-75. PubMed ID: 14729081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyelectrolyte-drug complexes of lambda carrageenan and basic drugs: relevance of particle size and moisture content on compaction and drug release behavior.
    Bonferoni MC; Sandri G; Rossi S; Ferrari F; Caramella C; Aguzzi C; Viseras C
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1188-95. PubMed ID: 18720148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex.
    Bonferoni MC; Rossi S; Ferrari F; Caramella C
    Pharm Dev Technol; 2004; 9(2):155-62. PubMed ID: 15202574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
    Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
    AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
    Krishnaiah YS; Karthikeyan RS; Satyanarayana V
    Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a diltiazem-lambda carrageenan complex.
    Bonferoni MC; Rossi S; Ferrari F; Bettinetti GP; Caramella C
    Int J Pharm; 2000 May; 200(2):207-16. PubMed ID: 10867250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
    Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
    Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release characteristics of tablets prepared with mixed matrix of sodium carrageenan and chitosan: effect of polymer weight ratio, dissolution medium, and drug type.
    Bani-Jaber A; Al-Ghazawi M
    Drug Dev Ind Pharm; 2005 Mar; 31(3):241-7. PubMed ID: 15830719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained release of highly water-soluble drugs with micelle forming ability from polyionic matrix tablets.
    Tanaka Y; Miyazaki Y; Yakou S; Takayama K
    Pharmazie; 2007 Jan; 62(1):41-5. PubMed ID: 17294812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the release mechanism of diltiazem hydrochloride from matrices based on chitosan-alginate and chitosan-carrageenan mixtures.
    Tapia C; Corbalán V; Costa E; Gai MN; Yazdani-Pedram M
    Biomacromolecules; 2005; 6(5):2389-95. PubMed ID: 16153073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride.
    Kim H; Fassihi R
    Pharm Res; 1997 Oct; 14(10):1415-21. PubMed ID: 9358555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.
    Kaialy W; Bello H; Asare-Addo K; Nokhodchi A
    J Pharm Pharmacol; 2016 Nov; 68(11):1396-1402. PubMed ID: 27714817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of delayed-onset extended-release tablets of metoprolol tartrate using hydrophilic-swellable polymers.
    Dadarwal SC; Madan S; Agrawal SS
    Acta Pharm; 2012 Mar; 62(1):105-14. PubMed ID: 22472453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
    Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
    Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.